We are live on ! Find out more
HQL

abrdn Life Sciences Investors

39 hedge funds and large institutions have $46.1M invested in abrdn Life Sciences Investors in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

22% more funds holding

Funds holding: 3239 (+7)

9% more capital invested

Capital invested by funds: $42.3M → $46.1M (+$3.8M)

0.15% more ownership

Funds ownership: 16.12%16.27% (+0.15%)

Holders
39
Holders Change
+7
Holders Change %
+21.88%
% of All Funds
1.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
16
Reduced
9
Closed
1
Calls
Puts
Net Calls
Net Calls Change

HQL Hedge Fund Activity: Q3 2013 in Review

39 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2013, worth a combined $46.1M — up 9% from $42.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new HQL positions and 1 closed out — a net gain of 7 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was National Planning Corporation, opening a new position worth an estimated $580K. The largest seller was Advisors Asset Management, cutting an estimated $2.43M.

  • 39 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2013, up from 32 in Q2 2013.
  • Funds reported $46.1M of abrdn Life Sciences Investors stock for Q3 2013, up 9% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q3 2013 and 1 closed out, a net change of +7 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2013 was National Planning Corporation, an estimated $580K added.
  • The largest abrdn Life Sciences Investors seller in Q3 2013 was Advisors Asset Management, an estimated $2.43M sold.

Based on aggregated 13F filings for Q3 2013.